Skip to main content
NeuronFeed
/ STARTUPS

All AI startups

61 startups tracked. Filter by category, country, funding stage, or whether they have an active deal.

SORT
On this page
25
of 61 total
Funding (page)
$1.8B
combined raised
Avg score
52
0 verified · 0 with deal
More filters
Reset

ChemLex

Singapore est. 2022

24/7 self-driving lab that runs autonomous chemistry to accelerate drug discovery

Drug Discovery
Raised
$45M
Stage
S-A
56

Insilico Medicine

United States

Accelerating drug discovery and development through generative AI and advanced bioinformatics platforms.

AI HealthcareDrug Discovery
Raised
$510M
Stage
S-E
55

Reveal HealthTech

United States est. 2023

Healthcare AI specialist building clinical trial and workflow automation products

AI HealthcareDrug Discovery
Raised
$7.2M
Stage
S-A
55

Apoha

United Kingdom est. 2023

AI for molecular behavior — the next data class after sequence and structure

Research AssistantsDrug Discovery
Raised
$36M
Stage
S-A
55

Terray Therapeutics

United States est. 2018

Generative AI and ultra-high-throughput chemistry for small-molecule drug discovery

AI HealthcareDrug Discovery
Raised
$180M
Stage
S-B
54

AI Proteins

United States est. 2021

Designing a new class of de novo miniprotein medicines with AI

AI HealthcareDrug Discovery
Raised
$59.7M
Stage
S-A
54

Perceptic

United Kingdom est. 2025

The AI operating system for pharmaceutical drug development

Drug Discovery
Raised
$12M
Stage
Seed
54

Basecamp Research

United Kingdom est. 2019

Building a GPT for biology from the planet's largest proprietary genomic dataset

Drug Discovery
Raised
$85M
Stage
S-B
54

Bindwell

Applies AI-driven molecular discovery techniques, originally developed for drug discovery, to

Drug Discovery
Raised
$6M
Stage
Seed
54

MOA Foodtech

Spain est. 2020

AI-driven biomass fermentation turning food waste into sustainable proteins

Drug DiscoveryAI Agriculture
Raised
$20M
Stage
Grant
53

Converge Bio

United States est. 2023

Generative AI hub of foundation models across DNA, RNA, protein, and small molecules

Drug Discovery
Raised
$30.5M
Stage
Seed
53

Excelsior Sciences

United States est. 2023

Novel modular chemistry that machines can run and AI can learn from

Drug Discovery
Raised
$95M
Stage
S-A
53

Noetik

United States est. 2021

Multimodal virtual-cell foundation models for precision oncology

Foundation ModelsDrug Discovery
Raised
$54M
Stage
S-A
53

Profluent

United States est. 2022

Frontier AI models for programmable biology and protein design

AI HealthcareDrug Discovery
Raised
$150M
Stage
S-B
52

Verley

France est. 2021

Precision-fermented, animal-free whey protein powered by AI bioprocess design

Drug DiscoveryAI Agriculture
Raised
$45M
Stage
S-A
51

Living Models

France est. 2024

AI foundation models for biology, starting with plant genomics

Drug Discovery
Raised
$7M
Stage
Seed
51

Superluminal Medicines

est. 2023

AI biotech company developing small-molecule drugs that target G protein-coupled receptors

Drug Discovery
Raised
$120M
Stage
S-A
51

Enjamb Labs

United States est. 2026

Full stack AI Agents accelerating Biopharma R&D

Drug Discovery
Raised
$500K
Stage
Seed
50

Trially

United States est. 2022

Agentic AI that enrolls clinical trials faster by converting patient matches

AI HealthcareDrug Discovery
Raised
$4.7M
Stage
Seed
50

RayThera

United States est. 2021

AI-driven small-molecule discovery for safer, more effective immunology drugs

Drug Discovery
Raised
$110M
Stage
S-A
50

Nabla Bio

United States est. 2021

Generative AI for de novo antibody and protein design against tough drug targets

Drug Discovery
Raised
$37M
Stage
S-A
49

Astraea

United States est. 2025

Agents that compress clinical trial biometrics from months to days.

AI AgentsAI Healthcare
Raised
$500K
Stage
Seed
48

Biomatter

LT est. 2019

Generative AI for protein and enzyme design across industries

Drug Discovery
Raised
$7M
Stage
Seed
48

Chai Discovery

United States est. 2023

Engineering better molecules using artificial intelligence for drug-like antibody design against challenging targets with atomic precision.

AI HealthcareDrug Discovery
Raised
$200M
Stage
S-B
46

Antiverse

United Kingdom est. 2017

Generative AI antibody design for challenging and undruggable targets

Drug Discovery
Raised
$18M
Stage
Seed
46